168 related articles for article (PubMed ID: 9373087)
1. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
Inagi K; Rodriquez AA; Ford CN; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of repeated botulinum toxin injections as a function of timing.
Inagi K; Ford CN; Rodriquez AA; Schultz E; Bless DM; Heisey DM
Ann Otol Rhinol Laryngol; 1997 Dec; 106(12):1012-9. PubMed ID: 9415596
[TBL] [Abstract][Full Text] [Related]
3. Physiologic assessment of botulinum toxin effects in the rat larynx.
Inagi K; Connor NP; Ford CN; Schultz E; Rodriquez AA; Bless DM; Pasic T; Heisey DM
Laryngoscope; 1998 Jul; 108(7):1048-54. PubMed ID: 9665255
[TBL] [Abstract][Full Text] [Related]
4. Effects of botulinum toxin on pathophysiology in spasmodic dysphonia.
Bielamowicz S; Ludlow CL
Ann Otol Rhinol Laryngol; 2000 Feb; 109(2):194-203. PubMed ID: 10685573
[TBL] [Abstract][Full Text] [Related]
5. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
Maronian NC; Waugh PF; Robinson L; Hillel AD
Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
[TBL] [Abstract][Full Text] [Related]
6. Office-based endoscopic botulinum toxin injection in laryngeal movement disorders.
Kaderbay A; Righini CA; Castellanos PF; Atallah I
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Jun; 135(3):205-207. PubMed ID: 29661610
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
Blitzer A
Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
[TBL] [Abstract][Full Text] [Related]
9. Laryngeal dystonia: case report and treatment with botulinum toxin.
Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
11. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
Boutsen F; Cannito MP; Taylor M; Bender B
J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
[TBL] [Abstract][Full Text] [Related]
12. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
Casserly P; Timon C
J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
[TBL] [Abstract][Full Text] [Related]
16. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
Ford CN; Bless DM; Lowery JD
Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
Davidson BJ; Ludlow CL
Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
19. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.
Lundy DS; Lu FL; Casiano RR; Xue JW
J Voice; 1998 Dec; 12(4):460-6. PubMed ID: 9988033
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Toxin Injections Into the Lateral Cricoarytenoid Muscles for Vocal Process Granuloma.
Pham Q; Campbell R; Mattioni J; Sataloff R
J Voice; 2018 May; 32(3):363-366. PubMed ID: 28778373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]